AWARDDELIVERY ORDERSmall business
Delivery order 75N91018F00002BIOMATRIX LLC
Overview
Award facts
- Net obligations
- $231.23K
- $231,229of $231.23K potential value
- Outlays (paid to date)
- $104.03K
- $104.03K paid of $231.23K obligated$104,030
- Period of performance
- Sep 29, 2018 to Sep 28, 2020
- Ended
- Modifications
- 4
- Latest action Nov 1, 2022
- Contract type
- Delivery order
- PIID 75N91018F00002
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
ORIGINAL SAYS: IGF::OT::IGF TISSUE SOURCE SITE (TSS) FOR NCI'S CLINICAL PROTEOMIC TUMOR ANALYSIS CONSORTIUM (CPTAC)PAYMENT 1-3 AT 85%.
Dates and value
- Award date
- Signed on Sep 14, 2018
- Potential end of performance
- Sep 27, 2020
- Current value
- $231,229Base and exercised options
- Potential value (if all options are exercised)
- $231,229
- Parent contract vehicle
- HHSN261201500046I (IDC, single award) — 3 orders recorded under it
Obligations by fiscal year of action
- FY2023: -$153,790 (de-obligation)
- FY2019: $272,691
- FY2018: $112,328
Total across 3 fiscal years: $231,229
Net de-obligation in that fiscal year (obligations withdrawn).
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Nov 1, 2022. View on USAspending · Recipient on SAM.gov
Recipient
NameBIOMATRIX LLC
LocationROCKVILLE, MD
UEIC1BSSVL1A7R8
CAGE code55DM2
Business sizeSmall businessSize at award, per the contracting officer
Organization typePartnership
Parent companyBIOMATRIX LLC
Business types and certifications
Women-ownedMinority-ownedFor-profit organizationLimited liability companyPartnership or LLP
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NIH NCI
- Funded from
- National cancer institute (0849)Program activities075-0849Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Rockville, Montgomery County, Maryland 20850-3075
- Congressional district (place of performance)
- MD-08As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- 6550IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS (product)
Competition
- Extent competed
- Competed under SAPF
- Solicitation procedures
- Simplified acquisitionSP1
- Set-aside
- Not reported
- Contract pricing
- Firm fixed priceJ
Solicitation and notices
- Solicitation ID
- RFQ N02CO5441702(as reported)
Contract details
- Subcontracting plan
- Plan not requiredB
- Major program
- Tissue source site (TSS)
- Certified cost or pricing data
- No
- Service Contract Act labor standards
- No
- Commercial procedures
- Commercial products/servicesA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Sep 14, 2018Base obligation at award: $112,328
- Latest action
- Nov 1, 2022 — Other administrative actionModification P00004; obligation change -$153,790; administrative: no change in scope or value
- Latest substantive action
- Aug 26, 2019 — Option exercisedModification P00003; obligation change +$166,541
- Latest funding action
- Jun 4, 2019 — Funding onlyModification P00002; obligation change +$86,303; funding only: changes obligations, not scope
- Actions by type
- Base award1
- Funding only2
- Option exercised1
- Other administrative action1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- Yes
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- -$153,790
- Latest action: change in base and all options
- -$153,790
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
- Walsh-Healey Act (materials and supplies)
- No
- Construction wage rates (Davis-Bacon)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Mfg in U.S.D
Structure
- Award or IDV
- Award
- Award type
- Delivery orderC
- Parent vehicle type
- IDCB
- Parent vehicle: multiple or single award
- Single awardS
- Parent vehicle agency
- National Institutes Of Health7529
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N910
- Transactions recorded under this award key
- 5
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N910
- Treasury accounts
- 075-2018/2018-0849-000
- 075-2019/2019-0849-000
- Object classes
- 25.5: Research and development contracts
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression